|

BOLD-100 +/- FOLFOX Chemotherapy (Arm VII) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: BOLD-100 +/- Folinic acid (leucovorin), Fluorouracil (5-FU), and Oxaliplatin.

Pipeline

Phase 1/2: 1

Top Sponsors

  • Bold Therapeutics, Inc.1

Indications

  • Gastric Cancers1
  • Cholangiocarcinoma1
  • Pancreatic Cancer1
  • Colorectal Cancer1
  • Cancer1

Santa Monica, California1 trial

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

University of California, Los Angeles

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.